Burning Rock Biotech (BNR) Interest Expenses (2019 - 2025)

Burning Rock Biotech (BNR) recorded quarterly Interest Expenses of -$2000.0 in Q4 2025, little changed quarter-over-quarter from -$2000.0 in Q3 2025.

Burning Rock Biotech (BNR) Interest Expenses (2019 - 2025) Analysis & Trends

Burning Rock Biotech's Interest Expenses history runs 4 years deep, the most recent figure standing at -$2000.0 for Q4 2025.

In Q4 2025, Interest Expenses changed N/A year-over-year to -$2000.0; the TTM figure through Dec 2025 stood at -$4000.0 (changed N/A YoY), while the FY2025 annual figure was -$4000.0, changed N/A from the prior year.
Interest Expenses was -$2000.0 for Q4 2025 at Burning Rock Biotech, roughly flat from -$2000.0 in the prior quarter.
In the past five years, Interest Expenses ranged from a high of -$2000.0 in Q3 2025 to a low of -$88000.0 in Q2 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Expense (Qtr)
1	Waters	29,149.49 Bn	29,149.03 Bn	1.11 Bn	48.00 Mn
2	Thermo Fisher Scientific	174.37 Bn	171.12 Bn	7.74 Bn	354.00 Mn
3	Danaher	127.33 Bn	121.64 Bn	3.59 Bn	63.00 Mn
4	Idexx Laboratories	44.68 Bn	44.48 Bn	722.74 Mn	7.74 Mn
5	Agilent Technologies	36.54 Bn	34.74 Bn	990.00 Mn	25.00 Mn
6	Iqvia Holdings	30.51 Bn	28.53 Bn	1.36 Bn	192.00 Mn
7	Natera	30.00 Bn	28.90 Bn	696.04 Mn	892,000.00
8	Illumina	24.61 Bn	23.45 Bn	721.00 Mn	24.00 Mn
9	Mettler Toledo International	22.91 Bn	22.85 Bn	555.82 Mn	17.01 Mn
10	Burning Rock Biotech	23.07 Mn	-44.76 Mn	14.10 Mn	-2,000.00

Download Data